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ABSTRACT 
 
 
Background: To plan and implement services to persons who inject drugs (PWID), 
knowing their number is essential. For the island of Montréal, Canada, the only estimate, 
of 11 700 PWID, was obtained in 1996 through a capture-recapture method. Thirteen 
years later, this study was undertaken to produce a new estimate. 
 
Methods: PWID were defined as individuals aged 14-65 years, having injected recently 
and living on the island of Montréal. The study period was 07/01/2009 to 06/30/2010. An 
estimate was produced using a six-source capture-recapture log-linear regression method. 
The data sources were two epidemiological studies and four drug dependence treatment 
centres. Model selection was conducted in two steps, the first focusing on interactions 
between sources and the second, on age group and gender as covariates and as 
modulators of interactions. 
 
Results: A total of 1 480 PWID were identified in the six capture sources. They 
corresponded to 1 132 different individuals. Based on the best-fitting model, which 
included age group and sex as covariates and six two-source interactions (some 
modulated by age), the estimated population was 3 910 PWID (95% confidence intervals 
(CI): 3 180-4 900) which represents a prevalence of 2.8 (95% CI: 2.3-3.5) PWID per 
1000 persons aged 14-65 years.  
 
Conclusions: The 2009-2010 estimate represents a two-thirds reduction compared to the 
one for 1996. The multisource capture-recapture method is useful to produce estimates of 
the size of the PWID population. It is of particular interest when conducted at regular 
intervals thus allowing for close monitoring of the injection phenomenon.  
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1. Introduction 
For decades, persons who inject drugs (PWID) have been known to be at high risk for 
HIV and hepatitis C virus (HCV) infections (Des Jarlais et al., 1988; Patrick et al., 2001; 
Shepard et al., 2005; Mathers et al., 2008; Joint United Nations Programme on 
HIV/AIDS, 2012). In addition, PWID are frequently affected by other negative health 
outcomes such as bacterial and fungal infections and fatal and non-fatal overdoses 
(Ochoa et al., 2001; Gordon and Lowy, 2005; Coffin et al., 2007; Hope et al., 2008). 
With injection drug use being identified in 148 countries and HIV infection among PWID 
being reported in 120 of these countries, drug injection represents a worldwide public 
health problem (Mathers et al, 2008).  
 
In Canada, PWID accounted for 14.0% of the HIV infections among adults reported in 
2012 (Public Health Agency of Canada, 2013) and, based on modelled data, for 58% of 
the HCV cases in the country in 2007 (Remis, 2009). In the island of Montréal, the 
setting for the present study, HIV and HCV infection rates remain among the highest for 
North American cities. Data gathered from 2003 to 2010 in the island of Montréal 
through SurvUDI, a PWID epidemiological surveillance network, indicated that 20.4% of 
participating PWID were HIV-infected and 68.5% were anti-HCV positive (Leclerc et al., 
2012). Amongst PWID, HIV incidence rate was estimated to be 3.1 per 100 person-years 
for the 1995 to 2010 period while HCV incidence rate was estimated to be 25.5 per 100 
person-years for the 2003 to 2010 period. (Leclerc et al., 2012).  
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In order to reduce the health risks associated with drug injection, several health and social 
scientists promote the development of structural interventions. These interventions, 
exogenous to individuals, aim to modify the social, legal, economic, cultural and policy 
environments in which drug injection health-related harms occur (Blankenship et al., 
2000; Des Jarlais, 2000). Increasing the availability of sterile injection equipment and 
drug treatments and accessibility to HIV and HCV screening and care are important 
structural interventions to reduce risks associated with drug injection. To optimize the 
coverage of such interventions, it is essential to have access to reliable estimates of the 
prevalence of injection drug use in the targeted population (Platt et al., 2004). 
Furthermore, as recommended by the World Health Organization, an estimate of the size 
of the PWID population in a given location is essential in order to provide optimal 
services to PWID (World Health Organization, 2009). 
 
Estimating the size of a PWID population is complicated by the fact that drug use is 
stigmatized and PWID form a hidden population that has limited contacts with official 
agencies. Hence, data available through agencies’ records or collected in the course of 
population surveys or epidemiological surveillance are deemed to be improper to 
estimate the size of the population, as they only account for the “known PWID 
population”.  
 
Indirect methods were developed to adjust for the under-ascertainment of such data 
sources. Among these methods, capture-recapture (CRC) is increasingly used to estimate 
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the size of hard-to-reach populations. CRC was initially developed in animal ecology and 
introduced in epidemiology in the 1970s by Wittes (Wittes et al., 1974; Wittes and Sidel, 
1968). It has been widely used to estimate the prevalence of problematic drug use around 
the world (Hser, 1993; Domingo-Salvany et al., 1998; Platt et al., 2004; Hickman et al., 
2004; Böhning et al., 2004; Chiang et al., 2007; Khazaei et al., 2012; Pérez et al., 2013; 
Uuskula et al., 2013).  
 
Estimates of the island of Montréal’s PWID population are scarce. In 1996, the PWID 
population was estimated in three Canadian cities (Montréal, Toronto and Vancouver). 
Using a three-source CRC method, the total estimated population of PWID for the island 
of Montréal was 11 700 [95% confidence interval (CI): 8 500 – 16 500] (Remis et al., 
1998). More than a decade later, an updated estimate was essential. This study was 
undertaken to estimate the number of PWID in the island of Montréal between July 1, 
2009 and June 30, 2010 using a CRC method. 
 
2. Methods 
2.1 Overview 
This study was carried out using a six-source CRC method. Based on the number of 
individuals identified in each source and the number of individuals present in more than 
one source, the CRC method allows estimating the number of individuals who have not 
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been observed in any of the sources and, consequently, the total number of individuals in 
the study population (Hook & Regal, 1995; 2000; Chao et al., 2001).  
 
In order to obtain asymptotically unbiased and efficient CRC estimates, four assumptions 
(or conditions) must be satisfied (Hook and Regal, 1995): 1- All identified individuals 
meet the definition of PWID, 2- All identified PWID are observed during the study 
period and in the targeted geographic region, 3- The studied population is closed and 4- 
All PWID matches (PWID present in more than one data source) and only true PWID 
matches are identified. 
 
When only two sources are available, two additional assumptions have to be satisfied, 
namely homogeneity of the capture probabilities (all individuals have the same 
probability of ascertainment within each source) and independence between the sources 
(presence of an individual in one source provides no information regarding her/his 
presence in the other). When more than two sources are available, log-linear regression 
models can account for these two types of potential dependencies by including interaction 
terms, as appropriate, between sources (Cormack, 1989; Hook & Regal, 1995; Chao et 
al., 2001). 
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2.2 Data sources and selection criteria 
Data for the estimation were obtained from the following sources: (1) SurvUDI, a PWID 
epidemiological surveillance network implemented in 1995 (Hankins et al., 2002; Leclerc 
et al., 2012), (2) the Saint-Luc Cohort, a PWID cohort study initiated in 1988 (Bruneau et 
al., 2011; Bruneau et al., 2012), and from four drug treatment centres (3) Service de 
médecine et de psychiatrie des toxicomanies du Centre Hospitalier de l’Université de 
Montréal (CHUM), a university hospital-based program offering medical and psychiatric 
integrated inpatient and outpatient services for patients with drug-related problems, (4) 
the Centre Dollard-Cormier Institut universitaire sur les dépendances (CDC-IUD, now 
called “Centre de réadaptation en dépendance de Montréal-Institut universitaire”) a 
centre offering detoxification and treatment in various settings including homeless and 
emergency clinics and inpatient services and evaluating individuals referred by the justice 
system, (5) the Centre de recherche et d’aide pour les narcomanes (Cran), a centre 
targeting opioid dependent individuals offering opioid-substitution treatment (OST), 
including a low-threshold clinic, and (6) the Foster Addiction Rehabilitation Centre 
(Foster-ARC), a centre with inpatient and outpatient facilities offering services mainly to 
the English-speaking population. 
 
Selection criteria were similar for all sources: being between 14 and 65 years of age; 
being a person who injects drugs (defined as having injected drugs at least once in the 
preceding 6 months); residing in the island of Montréal (including the homeless 
population); and appearing in a data source between July 1, 2009 and June 30, 2010. 
9	
	
2.3 Data collection 
SurvUDI and the Saint-Luc Cohort have electronic databases allowing for computerized 
identification of eligible participants. For the four treatment data sources, the preliminary 
identification of eligible patients was computerized but the final identification required 
manual review of patients’ files. To protect participant and patient confidentiality, 
identification of eligible subjects and data extraction were conducted by staff from each 
research project or treatment centre.  
 
2.4 Matching 
Routinely in the SurvUDI database, participants are identified by an encrypted code, 
based on their initials, date of birth and gender, generated at recruitment by a 
unidirectional encryption algorithm developed for the SurvUDI project. To match 
individuals between the six databases, the SurvUDI encryption algorithm was applied in 
the other five data sources. Only individuals with identical encrypted codes were 
considered matches. 
 
2.5 Analyses  
Inferential framework: In capture-recapture analyses with more than 2 sources, log-
linear models are used to estimate the number of “unobserved” individuals based on 
those observed (Cormack, 1989).  For our analyses, the observed individuals were 
distributed in a contingency table by data source (yes and no categories for each of 6 
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sources), gender (2 categories) and age group (5 categories), yielding an 8-dimensional, 
(26-1) ⨯ 2 ⨯ 5, contingency table. The age groups were selected so as to yield sufficiently 
large numbers in each group to avoid instability of the likelihood. The model selection 
process aimed at identifying a log-linear Poisson model that fitted this table well, taking 
into account interactions between sources and heterogeneity of captures (IWGDMF, 
1995). All models contained at minimum the intercept (identified with the missing cell 
value) and one parameter for each source. Because the number of possible models was 
very large, a heuristic approach was used for model selection. The sparseness of the 
contingency table dictated a staged model selection, to stave off the likelihood issues 
associated with random 0 cells (Christensen, 1997, Chapter 8). The stages consisted in 
considering first the sources and their interactions, then considering age and gender by 
themselves and in interaction with the selected sources. The overall approach is detailed 
below. 
 
Intermediate model: An intermediate model involving only source parameters and their 
interactions was first sought. Selection of this model took place by identifying all two-
source interactions of importance. Interactions were identified as either “required”, 
“possible” or “unneeded” according to prespecified criteria. “Required” interactions were 
identified successively as those uniformly improving Akaike’s Information Criterion 
(AIC; Akaike, 1974) over all models containing three two-way interactions and any 
previously identified required interactions; that is, any model containing the required 
interaction had better AIC than any model without. When no further required interaction 
could be identified, models containing all required interactions and three two-way 
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interactions were fitted. For each non-required interaction, an AIC average over all 
models containing the interaction was produced. An overall average AIC was also 
computed over all fitted models. “Possible” interactions were identified as those with 
associated average AIC lower than the overall average AIC. All remaining interactions 
were classified as “Unneeded” and removed from consideration. All log-linear models 
containing the required interactions, any subset of the possible interactions, and any 
subset of higher-order interactions allowed by the principle of hierarchy were then fitted 
(Goodman, 1970; Cormack, 1989). The intermediate model was selected in consideration 
of its AIC and significance of all terms. 
 
Final model: Age group and gender were considered for inclusion in the final model as 
simple covariates, as interactions with the sources, and as modulators of the interactions 
between sources retained in the intermediate model.  The number of possible models was 
still too high to test all of them. A bidirectional stepwise greedy algorithm, starting from 
several randomly chosen models, was used to identify a model with good AIC, using the 
intermediate model as smallest model. The algorithm sought at every step to optimise the 
AIC by adding or removing a single covariate or interaction. 
 
Production of estimates: Overall, age-specific, gender-specific and age-gender-specific 
population estimates were obtained using the exponentials of appropriate linear 
combinations of parameter estimates from the final model. Confidence intervals (CI) at 
the 95% level were obtained on the log-scale from the estimated parameter covariance 
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matrix and exponentiated. At this stage, potential overdispersion was accounted for by 
using quasi-likelihood maximization (Wedderburn, 1974). 
 
All regression analyses were carried out using R version 3.0.0 (R Core Team, 2013). 
Descriptive analyses for the six databases were carried out using SPSS version 12.0.2 
(SPSS Inc., 2003) 
 
The census population for the island of Montréal was used to calculate the prevalence 
rate of injection drug use. The denominator was the projected population for 2009-2010 
aged between 14-65 years (N=1 392 092) (Institut de la statistique du Québec, 2006).  
 
Completeness of data collected by all sources was estimated with its 95% CI by 
comparing the number of PWID observed to the total number of PWID estimated by the 
best fitting log-linear model, as well as the upper and lower limits of its 95% CI.   
 
2.6 Ethical approval 
Ethical approval for the present study was obtained from the Comité d’éthique de la 
recherche de l’Agence de la santé et des services sociaux de Montréal. Ethical approvals 
were also obtained from the Comité d’éthique de la recherche sur les sujets humains du 
CHUM for the Saint-Luc cohort and the CHUM’s Service de médecine et de psychiatrie 
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des toxicomanies, the Comité d’éthique de la recherche en toxicomanie for the CDC-
IUD, CRAN and Foster-ARC, the Institutional Review Board of McGill University for 
SurvUDI and by the Ethics Board of Health Canada research and the Public Health 
Agency of Canada. 
 
3. Results 
A total of 1480 PWID were identified in the six capture sources; their number varied 
from 31 to 432 per source (Table 1). The 1480 identified PWID corresponded to 1132 
distinct individuals. Table 1 shows their distribution across the sources. A total of 278 
cases of overlap between sources were observed. Of these, 4 were present in 4 data 
sources, 61 in 3 data sources and 213 in 2 data sources. Overall, 78.8% of the identified 
PWID were male (ranging from 83.3% in SurvUDI to 48.4% in Foster-ARC) and 59.3% 
were more than 36 years old (ranging from 43.3% in CRAN to 62.1% in the Saint-Luc 
cohort). 
 
The best fitting model obtained using the approach detailed in 2.5, is schematically 
represented in Figure 1. It includes age group and sex as significant covariates as well as 
6 interactions between 2 sources, 2 of which are modulated by age (i.e. there are 2 three-
way interactions between age group and two of the sources). Five data source main 
effects interact with sex, and 3 with age group.  Based on this model, the estimated PWID 
population size in the island of Montréal for the period July 1, 2009 to June 30, 2010 is 
3910 PWID (95% CI:  3180 – 4900).  Table 2 presents the total PWID population 
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distributed by age group and gender. The estimated population represents a prevalence of 
2.8 (95% CI: 2.3-3.5) PWID per 1000 residents among the population aged 14-65 years. 
Men accounted for 72.1% of the total population and 63.2% of PWID had more than 36 
years. 
 
The estimated completeness rate of all data sources was 29.0% (1132/3910) and its 95% 
CI ranged from 23.1 to 35.6%. 
 
4. Discussion 
This study is one of the few on the size of the PWID population in Canada.  This estimate 
is crucial to the planning of public health programs targeting injection drug use related 
harms at the population level.  Using a six-source CRC analysis, the total number of 
PWID in 2009-2010 was estimated to be 3910 (95% CI: 3180 – 4900) for the island of 
Montréal, for a prevalence of 2.8 (95% CI: 2.3-3.5) PWID per 1000 residents aged 14-65 
years. The PWID population of the island of Montréal is largely male and only one fifth 
of PWID are 30 years or younger.  
 
4.1. Credibility of the estimate 
As stated in section 2.1, four underlying assumptions are required to use the CRC method 
appropriately. They seem to have been sufficiently satisfied in the present study. 1- All 
sources included thorough data on drug consumption during the studied period which 
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allowed identification of individuals who met the definition of PWID. In the treatment 
data sources, an individual might have omitted to report injection, but the opposite, which 
would have more impact on the produced estimate, seems rather unlikely. As for the 
SurvUDI and St-Luc Cohort projects, there is a possibility that individuals may have 
falsely reported injecting drugs in order to participate (and receive the financial 
compensation). However, this possibility is minimized by the training of the recruitment 
staff of both studies. 
 
2- In all sources, data were available on the date or dates that each PWID was in contact 
with the data source and on his/her living area. We can thus be confident that the second 
assumption was not violated since all data collected pertain to the study period and the 
targeted geographical area.   
 
3- There is a potential bias associated with violation of the closed population assumption. 
Using a short reference period has been suggested as a way to minimize the impact of this 
bias (Domingo-Salvany et al., 1998). Population movements should have been limited 
during the chosen one year period. 
 
4- In order to ensure that all PWID matches and only true PWID matches were identified, 
matching of individuals across sources was based on the perfect concordance of the 
encrypted codes (generated from gender, date of birth and initials). The quality of the 
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identifying data is highly important for the matching process. These data can be 
considered reliable and complete in the treatment data sources and in the Saint-Luc 
cohort. However, for SurvUDI, they are not required to be confirmed by an identification 
card. This could have led to an underestimate of the number of matches involving the 
SurvUDI database. Conversely, basing matches only on gender, date of birth and initials 
of PWID may have produced false matches if two individuals of the same gender 
happened to have the same initials and the same date of birth. However, given the limited 
size of the population, one can suppose that this effect is marginal. 
 
As for the additional assumptions of homogeneity of the capture probabilities and 
independence between sources they are addressed through the log-linear modelling. 
Indeed, the rather sizeable dependency phenomenon detected highlights that even 
exploratory analyses involving only two sources, or three or more sources under the 
independence assumption, would have been potentially misleading and have produced 
results biased toward zero in most cases. Without discussing all retained interactions, it is 
worthy to note that the positive one between the Saint-Luc cohort and SurvUDI sources, 
and their individual interactions with age group and sex, seem coherent with data from 
the field. Indeed, both studies are largely recruiting from the same community-based 
organisations distributing free sterile injection equipment (Hankins et al., 2002; Leclerc 
et al., 2012; Bruneau et al., 2011; Bruneau et al., 2012). The clientele of these 
organisations are mainly men, with male clients older than female clients (Leclerc et al. 
2009). 
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Despite satisfying adherence to the underlying assumptions, some caution regarding the 
obtained estimate is necessary. The number of PWID in the island of Montréal for 2009-
2010 could be underestimated to the extent that some PWID have a null probability of 
being included in any of the six data sources. Such individuals may exist, but the 
diversity of the data sources greatly limits their number. Among them, there were 
different types of institutional settings, including a low-threshold addiction treatment 
facility (one of the clinics of the CRAN) and tertiary health care facilities (CHUM). Data 
sources also included various community-based settings, via SurvUDI and the Saint-Luc 
cohort projects, and the judiciary system through the CDC-IUD. In addition, they covered 
different geographic areas of the island of Montréal and some served predominantly the 
French-speaking population and others served mostly the English-speaking population. 
 
4.2. Comparison with the 1996 estimate 
The estimated PWID population size for the island of Montréal in 2009-2010 represents a 
two-thirds reduction compared to the one obtained by Remis et al. (1998) for 1996 (also 
using the CRC method).  Despite the absence of data regarding fluctuations between 
these two estimates, their comparison seemed of interest especially since data sources and 
methods were similar for both studies. Hypotheses regarding possible demographic, 
behavioural and environmental changes can be formulated in an attempt to explain the 
observed difference. 
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Several studies have demonstrated that PWID have higher rates of premature deaths 
compared to the general population (Miller et al., 2007; Quan et al., 2010; European 
Monitoring Centre for Drugs and Drug Addiction, 2011; Evans et al., 2012). While an 
increase in the mortality rate could be a plausible explanation for the reduction of the 
PWID population between the two periods, no available data seem to corroborate this 
hypothesis. Indeed, recent data on AIDS-related deaths for the province of Québec show 
a significant decrease in mortality since the mid-1990s for all exposure categories (Blouin 
et al. 2012). Furthermore, an analysis of the data from the Québec coroner's office 
showed no change in the annual number of deaths due to injection related overdoses 
between 2000 and 2009 for the island of Montréal (Leclerc et al., 2013a). 
 
Another hypothesis could involve changes in PWID movements between the island of 
Montréal and other regions of the province of Québec. Between 1996 and 2009-2010, 
harm reduction programs, including distribution of sterile injection equipment (Noël and 
Cloutier, 2009; Noël et al., 2011) and OST (Centre de Recherche et d’Aide aux 
Narcomanes, 2011) developed significantly both in the island of Montréal and elsewhere 
in the province. This may have led to a decrease in the number of individuals leaving less 
urban regions of Québec to settle in the island of Montréal and an increase in the number 
of PWID leaving the island of Montréal to return to their hometown. In addition, since 
OST programs have previously been associated with injection cessation (Goldstein et al., 
2000; Galai et al., 2003; Shah et al., 2006; Evans et al., 2009), an increased offer in the 
island of Montréal may have resulted in a higher rate of injection cessation which could 
have contributed to the observed reduction of the PWID population. However, the impact 
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of OST programs is limited to opioid users while cocaine is the most often injected drug 
in the island of Montréal (Leclerc et al., 2013b). 
 
Furthermore, the observed decrease in population size may be due to a decrease in the 
rate of initiation into injection between the two studies. In this regard, it is of interest to 
underline a media campaign aimed at preventing initiation into drug injection among 
street youth that was held in Montréal in 2005 (Roy et al., 2007). Among Montréal’s 
street youth, the proportion reporting having ever injected drugs was 47% at entry in a 
cohort conducted from 1995 to 2000 (Roy et al., 2003) while it was 24% in a study 
conducted in 2011-2012 (Leclerc et al., 2013c). And in 2008-2010, a study exploring 
subgroups of cocaine users in downtown Montréal showed that young users (≤24 years) 
were proportionally more present in the subgroups where minimal injection was observed 
(Roy et al., 2013). A reduction of the PWID population could be explained by 
generational differences regarding drug use (Broz and Ouellet, 2008; Gamella, 1994; 
Golub and Johnson, 1999; Golub et al., 2005; van Ameijden and Coutinho, 2001) with 
new (young) drug users, who witnessed the adverse consequences of injection, choosing 
other modes of drug administration or other drugs.   
 
Finally, the reduction of the size of the PWID population between the two studies may be 
attributable to environmental factors such as the drug market, which is recognised as an 
important modulator of drug use behaviours at the individual and social levels (Gamella, 
1994; Stimson and Choopanya, 1998; Sterk and Elifson, 2000; Ciccarone, 2009). In the 
20	
	
island of Montréal, surveillance data have shown a significant increase of crack smoking 
from the early 2000s (Leclerc et al., 2013b; Leclerc et al., 2012). Also, ethnographic 
work conducted in downtown Montréal in 1997-1998 (Bourgois, 1997; Bourgois and 
Bruneau, 2000) and in 2007-2009 (Roy et al., 2012) suggest that on the street, since the 
beginning of the 2000s, ready-to-smoke crack has gradually surpassed the traditionally 
dominating powder cocaine (which is easily dissolvable for injection) . Since associations 
were observed between the forms of drugs available on the market and the modes of 
consumption used (Gamella, 1994; de la Fuente et al., 1996; Sotheran et al., 1999), it is 
plausible that the arrival of crack on the drug market contributed to the reduction of 
injection drug use as it was observed elsewhere in the world (van Ameijden and 
Coutinho, 2001; Bourgois, 2003a; 2003b; Inciardi et al, 2006). 
 
While several hypotheses can be formulated regarding the decrease of the PWID 
population in the island of Montréal between 1996 and 2009-2010, it is most likely due to 
a combination of causes. The substantial gap in time between the two estimates also 
complicates the understanding of such a change. To better understand the changes that 
affect the PWID population of the island of Montréal, we believe that estimates of its size 
should be obtained at more regular intervals, such as every five years. Trends would thus 
be easier to follow and, consequently, planning of prevention and treatment programs 
would be optimized. 
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4.3. Conclusion 
As other studies have demonstrated (Hser, 1993; Domingo-Salvany et al., 1998; Platt et 
al., 2004; Hickman et al., 2004; Böhning et al., 2004; Chiang et al., 2007; Khazaei et al., 
2012; Pérez et al., 2013; Uuskula et al., 2013), the CRC approach, despite its limitations, 
is useful to estimate the size of PWID populations. This approach can be of particular 
interest when conducted at regular intervals thus allowing for close monitoring of the 
injection phenomenon and optimal provision of services to this high-risk population. 
Since unbiased CRC estimates are highly dependent on the quality of the data, reliable 
data sources should be seen as priorities by public health authorities.  
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Table 1. Distribution of eligible PWID across the six data sources*  
 
SurvUDI Saint-Luc Cohort CDC-IUD CRAN CHUM 
Foster-
ARC 
Number of 
eligible 
PWID 
 yes yes yes no yes no 2 
 yes yes no yes yes no 1 
 no yes yes yes yes no 1 
 yes yes no no yes no 13 
 yes yes yes no no no 24 
 yes yes no yes no no 12 
 yes no yes no yes no 4 
 no yes yes no yes no 3 
 no yes no yes yes no 1 
 no yes yes yes no no 2 
 no no yes yes yes no 1 
 no no yes no yes yes 1 
 yes yes no no no no 96 
 yes no no no yes no 3 
 yes no yes no no no 24 
 yes no no yes no no 6 
 yes no no no no yes 2 
 no yes no no yes no 8 
 no yes yes no no no 26 
 no yes no yes no no 27 
 no yes no no no yes 1 
 no no yes no yes no 12 
 no no no yes yes no 1 
 no no yes yes no no 5 
 no no yes no no yes 2 
 yes no no no no no 245 
 no yes no no no no 202 
 no no no no yes no 72 
 no no yes no no no 217 
 no no no yes no no 93 
 no no no no no yes 25 
Number of 
eligible 
PWID per 
data source 432 420 150 123 324 31  
        
* SurvUDI (PWID epidemiological surveillance network); Saint-Luc Cohort (PWID Cohort);  Drug treatment centres: 
CDC-IUD (Centre Dollard-Cormier Institut universitaire sur les dépendances), CRAN (Centre de recherche et d’aide 
pour les narcomanes), CHUM (Service de médecine et de psychiatrie du Centre hospitalier de l’université de 
Montréal), and Foster-ARC (Foster-Addiction Rehabilitation Centre). 
  
 Table 2. Capture-recapture estimates* for PWID aged 14 to 65 years in the island of Montréal 
distributed by age group and gender 
 Estimated female 
population 
n (95% CI) 
Estimated male 
population 
n (95% CI) 
Estimated total 
population 
n (95% CI) 
14-30 years 170 (120-260) 530 (430-690) 710 (560-920) 
31 - 36 years 180 (130-270) 550 (440-700) 730 (580-950) 
37 - 42 years 230 (170-340) 610 (480-800) 840 (660-1110) 
43 - 48 years 250 (180-360) 620 (480-820) 870 (680-1150) 
49 - 65 years 240 (190-330) 510 (400-680) 760 (600-1000) 
Total 1090 (810-1500) 2820 (2300-3540) 3910 (3180-4900) 
* Results rounded to nearest ten. Subgroup estimates may not sum to stated total due to rounding.” 
Figure 1. 
 
 
SurvUDI (PWID epidemiological surveillance network); Saint-Luc (PWID Cohort);  Drug treatment centres: CHUM 
(Service de médecine et de psychiatrie du Centre hospitalier de l’université de Montréal), CDC (Centre Dollard-
Cormier Institut universitaire sur les dépendances), CRAN (Centre de recherche et d’aide pour les narcomanes) and 
Foster-ARC (Foster-Addiction Rehabilitation Centre). 
 
